HK1215434A1 - 取代的嘧啶衍生物 - Google Patents

取代的嘧啶衍生物

Info

Publication number: HK1215434A1
Authority: HK; Hong Kong
Prior art keywords: pyrimidine derivatives; substituted pyrimidine; substituted; derivatives; pyrimidine
Prior art date: 2008-06-30

Application number

HK16103405.5A

Other languages

English (en)

Inventor

Cesco-Cancian Sergio

Chen Hongfeng

S Grimm Jeffrey

S Mani Neelakandha

M Mapes Christopher

C Palmer David

J Pippel Daniel

L Sorgi Kirk

Xiao Tong

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-30

Filing date

2016-03-23

Publication date

2016-08-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41464882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1215434(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-03-23 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2016-08-26 Publication of HK1215434A1 publication Critical patent/HK1215434A1/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C211/22—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HK16103405.5A 2008-06-30 2016-03-23 取代的嘧啶衍生物 HK1215434A1 (zh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7675208P	2008-06-30	2008-06-30

Publications (1)

Publication Number	Publication Date
HK1215434A1 true HK1215434A1 (zh)	2016-08-26

Family

ID=41464882

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
HK11111216.2A HK1156857A1 (zh)	2008-06-30	2011-10-19	取代的嘧啶衍生物的製備方法
HK15101911.7A HK1201441A1 (zh)	2008-06-30	2015-02-26	取代的嘧啶衍生物的製備方法
HK16102449.5A HK1214590A1 (zh)	2008-06-30	2016-03-03	哌啶和哌嗪衍生物
HK16103405.5A HK1215434A1 (zh)	2008-06-30	2016-03-23	取代的嘧啶衍生物

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
HK11111216.2A HK1156857A1 (zh)	2008-06-30	2011-10-19	取代的嘧啶衍生物的製備方法
HK15101911.7A HK1201441A1 (zh)	2008-06-30	2015-02-26	取代的嘧啶衍生物的製備方法
HK16102449.5A HK1214590A1 (zh)	2008-06-30	2016-03-03	哌啶和哌嗪衍生物

Country Status (36)

Country	Link
US (6)	US8309720B2 (zh)
EP (5)	EP2924035A1 (zh)
JP (1)	JP5416768B2 (zh)
KR (1)	KR101675354B1 (zh)
CN (1)	CN102137672B (zh)
AR (1)	AR072396A1 (zh)
AU (1)	AU2009267156B2 (zh)
BR (1)	BRPI0913644A2 (zh)
CA (1)	CA2729733C (zh)
CO (1)	CO6341560A2 (zh)
CY (1)	CY1116134T1 (zh)
DK (1)	DK2310012T3 (zh)
EA (1)	EA019361B1 (zh)
EC (1)	ECSP11010745A (zh)
ES (1)	ES2538135T3 (zh)
HK (4)	HK1156857A1 (zh)
HR (1)	HRP20150576T1 (zh)
HU (1)	HUE024949T2 (zh)
IL (4)	IL210214A (zh)
JO (1)	JO3043B1 (zh)
ME (1)	ME02154B (zh)
MX (1)	MX2011000080A (zh)
MY (1)	MY150601A (zh)
NI (1)	NI201000232A (zh)
NZ (1)	NZ590170A (zh)
PE (1)	PE20110163A1 (zh)
PL (1)	PL2310012T3 (zh)
PT (1)	PT2310012E (zh)
RS (1)	RS53985B1 (zh)
SI (1)	SI2310012T1 (zh)
SV (1)	SV2011003788A (zh)
TW (3)	TW201433568A (zh)
UA (1)	UA106724C2 (zh)
UY (1)	UY31949A (zh)
WO (1)	WO2010002774A1 (zh)
ZA (1)	ZA201100759B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101460483B (zh)	2006-03-31	2013-05-08	詹森药业有限公司	作为组胺h4受体调节剂的苯并咪唑-2-基嘧啶和吡嗪
EP2924035A1 (en)	2008-06-30	2015-09-30	Janssen Pharmaceutica NV	Substituted pyrimidine derivatives
US9371311B2 (en)	2008-06-30	2016-06-21	Janssen Pharmaceutica Nv	Benzoimidazol-2-yl pyrimidine derivatives
JP5574294B2 (ja) *	2010-11-04	2014-08-20	独立行政法人科学技術振興機構	光磁気記録媒体及び光磁気記録方法
WO2014138368A1 (en)	2013-03-06	2014-09-12	Janssen Pharmaceutica Nv	Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
US10202337B2 (en)	2014-03-28	2019-02-12	Kaneka Corporation	Method for producing tri-carbobenzoxy-arginine
JP7102404B2 (ja)	2016-11-03	2022-07-19	ブリストル－マイヤーズスクイブカンパニー	置換窒素含有化合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3005852A (en)	1959-12-22	1961-10-24	Gen Aniline & Film Corp	Production of sulfoxides and sulfones
US3931195A (en) *	1971-03-03	1976-01-06	Mead Johnson & Company	Substituted piperidines
US4191828A (en) *	1976-04-14	1980-03-04	Richardson-Merrell Inc.	Process for preparing 2-(2,2-dicyclohexylethyl)piperidine
US4190601A (en) *	1978-05-31	1980-02-26	Union Carbide Corporation	Production of tertiary amines by reductive alkylation
JPS5942396A (ja) *	1982-09-02	1984-03-08	Ishihara Sangyo Kaisha Ltd	リン酸アミド誘導体およびそれらを含有する殺虫、殺ダニ、殺線虫剤
JPS6130576A (ja)	1984-07-24	1986-02-12	Ube Ind Ltd	２−アミノ−５−シアノピリミジンの製法
AU674553B2 (en) *	1992-10-14	1997-01-02	Merck & Co., Inc.	Fibrinogen receptor antagonists
GB9422391D0 (en)	1994-11-05	1995-01-04	Solvay Interox Ltd	Oxidation of organosulphur compounds
NZ506417A (en)	1998-02-17	2003-05-30	Tularik Inc	Anti-viral pyrimidine derivatives
GB9914258D0 (en) *	1999-06-18	1999-08-18	Celltech Therapeutics Ltd	Chemical compounds
KR20020047198A (ko) *	1999-09-30	2002-06-21	해피 페너 ; 해리 에이치. 페너 2세	특정 알킬렌 디아민-치환된피라졸로[1,5-ａ]-1,5-피리미딘 및피라졸로[1,5-ａ]-1,3,5-트리아진
UA75888C2 (uk)	2000-07-21	2006-06-15	Сінгента Партісіпейшнс Аг	Спосіб одержання 4,6-диметокси-2-(метилсульфоніл)-1,3-піримідину
PE20020506A1 (es) *	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US20030130264A1 (en)	2001-02-16	2003-07-10	Tularik Inc.	Methods of using pyrimidine-based antiviral agents
JP2004525150A (ja) *	2001-03-30	2004-08-19	スミスクラインビーチャムコーポレーション	治療用化合物としてのピラゾロピリジン類の使用
DE60210819T2 (de) *	2001-12-17	2007-04-19	Smithkline Beecham Corp.	Pyrazolopyridazinderivate
TWI270542B (en)	2002-02-07	2007-01-11	Sumitomo Chemical Co	Method for preparing sulfone or sulfoxide compound
DE60329030D1 (de) *	2002-12-04	2009-10-08	Ore Pharmaceuticals Inc	Melanocortin-rezeptormodulatoren
EP1622910A1 (en) *	2003-05-05	2006-02-08	F. Hoffmann-La Roche Ag	Fused pyrimidine derivatives with crf activity
WO2006047687A2 (en)	2004-10-27	2006-05-04	Schering Corporation	Compositions and methods for short interfering nucleic acid inhibition of nav1.8
US7589197B2 (en)	2005-06-14	2009-09-15	Taigen Biotechnology	Pyrimidine compounds
US8309709B2 (en) *	2005-07-06	2012-11-13	Ge Healthcare Bio-Sciences Ab	Method of preparing a separation matrix
TW200800201A (en) *	2005-11-18	2008-01-01	Lilly Co Eli	Pyrimidinyl benzothiophene compounds
CN101032483B (zh) *	2006-03-09	2011-05-04	陈德桂	调节雄激素受体活性的乙内酰脲衍生物及其应用
ATE479678T1 (de) *	2006-03-31	2010-09-15	Janssen Pharmaceutica Nv	Benzoimidazol-2-yl pyridine als modulatoren des histamin-h4-rezeptors
CN101460483B (zh) *	2006-03-31	2013-05-08	詹森药业有限公司	作为组胺h4受体调节剂的苯并咪唑-2-基嘧啶和吡嗪
EP2924035A1 (en)	2008-06-30	2015-09-30	Janssen Pharmaceutica NV	Substituted pyrimidine derivatives
EA020090B1 (ru) *	2008-06-30	2014-08-29	Янссен Фармацевтика Нв	Способ получения и рекристаллизации кристаллического гемитартрата бензоимидазол-2-илпиримидинового производного

2009
- 2009-06-29 EP EP15157445.6A patent/EP2924035A1/en not_active Withdrawn
- 2009-06-29 MX MX2011000080A patent/MX2011000080A/es active IP Right Grant
- 2009-06-29 DK DK09774225T patent/DK2310012T3/da active
- 2009-06-29 TW TW103118001A patent/TW201433568A/zh unknown
- 2009-06-29 HU HUE09774225A patent/HUE024949T2/en unknown
- 2009-06-29 JO JOP/2009/0240A patent/JO3043B1/ar active
- 2009-06-29 ME MEP-2015-79A patent/ME02154B/me unknown
- 2009-06-29 UA UAA201100983A patent/UA106724C2/uk unknown
- 2009-06-29 PL PL09774225T patent/PL2310012T3/pl unknown
- 2009-06-29 CN CN200980134933.7A patent/CN102137672B/zh not_active Expired - Fee Related
- 2009-06-29 ES ES09774225.8T patent/ES2538135T3/es active Active
- 2009-06-29 AR ARP090102405 patent/AR072396A1/es not_active Application Discontinuation
- 2009-06-29 AU AU2009267156A patent/AU2009267156B2/en not_active Ceased
- 2009-06-29 EP EP20140161564 patent/EP2769721A3/en not_active Withdrawn
- 2009-06-29 EP EP20090774225 patent/EP2310012B1/en active Active
- 2009-06-29 RS RS20150287A patent/RS53985B1/en unknown
- 2009-06-29 CA CA2729733A patent/CA2729733C/en not_active Expired - Fee Related
- 2009-06-29 WO PCT/US2009/049027 patent/WO2010002774A1/en active Application Filing
- 2009-06-29 BR BRPI0913644A patent/BRPI0913644A2/pt not_active Application Discontinuation
- 2009-06-29 NZ NZ590170A patent/NZ590170A/en not_active IP Right Cessation
- 2009-06-29 PT PT97742258T patent/PT2310012E/pt unknown
- 2009-06-29 MY MYPI2010006258A patent/MY150601A/en unknown
- 2009-06-29 EP EP15157463.9A patent/EP2924025A1/en not_active Withdrawn
- 2009-06-29 TW TW103104509A patent/TWI481603B/zh not_active IP Right Cessation
- 2009-06-29 KR KR1020117001991A patent/KR101675354B1/ko not_active Expired - Fee Related
- 2009-06-29 SI SI200931188T patent/SI2310012T1/sl unknown
- 2009-06-29 EA EA201170113A patent/EA019361B1/ru not_active IP Right Cessation
- 2009-06-29 PE PE2010001216A patent/PE20110163A1/es not_active Application Discontinuation
- 2009-06-29 EP EP15157453.0A patent/EP2924023A1/en not_active Withdrawn
- 2009-06-29 TW TW098121755A patent/TWI498326B/zh not_active IP Right Cessation
- 2009-06-29 US US12/459,229 patent/US8309720B2/en not_active Expired - Fee Related
- 2009-06-29 JP JP2011516757A patent/JP5416768B2/ja not_active Expired - Fee Related
- 2009-06-30 UY UY31949A patent/UY31949A/es unknown
2010
- 2010-12-23 NI NI201000232A patent/NI201000232A/es unknown
- 2010-12-23 IL IL210214A patent/IL210214A/en active IP Right Grant
2011
- 2011-01-03 SV SV2011003788A patent/SV2011003788A/es unknown
- 2011-01-04 CO CO11000461A patent/CO6341560A2/es not_active Application Discontinuation
- 2011-01-05 EC ECSP11010745 patent/ECSP11010745A/es unknown
- 2011-01-28 ZA ZA2011/00759A patent/ZA201100759B/en unknown
- 2011-10-19 HK HK11111216.2A patent/HK1156857A1/zh not_active IP Right Cessation
2012
- 2012-10-29 US US13/663,233 patent/US9079882B2/en not_active Expired - Fee Related
2013
- 2013-03-15 US US13/844,227 patent/US9079883B2/en not_active Expired - Fee Related
- 2013-11-11 US US14/076,955 patent/US9079884B2/en not_active Expired - Fee Related
- 2013-11-12 US US14/078,153 patent/US9006432B2/en not_active Expired - Fee Related
- 2013-11-13 US US14/079,358 patent/US9359327B2/en not_active Expired - Fee Related
2014
- 2014-11-09 IL IL235571A patent/IL235571A/en active IP Right Grant
- 2014-11-09 IL IL235570A patent/IL235570A/en active IP Right Grant
- 2014-11-09 IL IL235572A patent/IL235572A/en active IP Right Grant
2015
- 2015-02-26 HK HK15101911.7A patent/HK1201441A1/zh unknown
- 2015-03-23 CY CY20151100293T patent/CY1116134T1/el unknown
- 2015-05-29 HR HRP20150576TT patent/HRP20150576T1/hr unknown
2016
- 2016-03-03 HK HK16102449.5A patent/HK1214590A1/zh unknown
- 2016-03-23 HK HK16103405.5A patent/HK1215434A1/zh unknown

Also Published As

Publication number	Publication date
TWI481603B (zh)	2015-04-21
EA201170113A1 (ru)	2011-08-30
US20100004450A1 (en)	2010-01-07
HUE024949T2 (en)	2016-02-29
CN102137672A (zh)	2011-07-27
EP2310012A1 (en)	2011-04-20
HK1201441A1 (zh)	2015-09-04
HRP20150576T1 (hr)	2015-09-11
TW201420583A (zh)	2014-06-01
AR072396A1 (es)	2010-08-25
MX2011000080A (es)	2011-03-02
TW201433568A (zh)	2014-09-01
HK1214590A1 (zh)	2016-07-29
NZ590170A (en)	2012-04-27
CA2729733C (en)	2016-10-25
IL210214A0 (en)	2011-03-31
US9079884B2 (en)	2015-07-14
KR101675354B1 (ko)	2016-11-11
PT2310012E (pt)	2015-04-02
SV2011003788A (es)	2011-02-08
EP2924023A1 (en)	2015-09-30
AU2009267156A1 (en)	2010-01-07
US9006432B2 (en)	2015-04-14
KR20110023901A (ko)	2011-03-08
US20140121374A1 (en)	2014-05-01
PL2310012T3 (pl)	2015-08-31
NI201000232A (es)	2011-09-07
TW201012810A (en)	2010-04-01
AU2009267156B2 (en)	2015-05-28
US9079882B2 (en)	2015-07-14
US20130053561A1 (en)	2013-02-28
ME02154B (me)	2015-10-20
IL235571A (en)	2016-09-29
US20140073795A1 (en)	2014-03-13
CN102137672B (zh)	2014-03-26
CY1116134T1 (el)	2017-02-08
HK1156857A1 (zh)	2012-06-22
ZA201100759B (en)	2012-07-25
DK2310012T3 (da)	2015-03-30
PE20110163A1 (es)	2011-03-28
US20130225816A1 (en)	2013-08-29
EP2769721A2 (en)	2014-08-27
TWI498326B (zh)	2015-09-01
UA106724C2 (uk)	2014-10-10
RS53985B1 (en)	2015-10-30
MY150601A (en)	2014-01-30
EP2769721A3 (en)	2015-04-01
IL210214A (en)	2016-07-31
US9359327B2 (en)	2016-06-07
EP2310012A4 (en)	2012-06-20
EA019361B1 (ru)	2014-03-31
WO2010002774A1 (en)	2010-01-07
EP2924035A1 (en)	2015-09-30
UY31949A (es)	2010-01-29
BRPI0913644A2 (pt)	2015-11-24
SI2310012T1 (sl)	2015-06-30
IL235570A (en)	2016-08-31
JP2011526910A (ja)	2011-10-20
ECSP11010745A (es)	2011-02-28
CO6341560A2 (es)	2011-11-21
US9079883B2 (en)	2015-07-14
EP2310012B1 (en)	2015-03-04
IL235572A (en)	2016-09-29
ES2538135T3 (es)	2015-06-17
JP5416768B2 (ja)	2014-02-12
EP2924025A1 (en)	2015-09-30
US20140066624A1 (en)	2014-03-06
JO3043B1 (ar)	2016-09-05
CA2729733A1 (en)	2010-01-07
US8309720B2 (en)	2012-11-13

Publication	Publication Date	Title
IL210176A0 (en)	2011-03-31	Substituted pyrimidone derivatives
HK1256310A1 (zh)	2019-09-20	N-磺酰基吡咯衍生物
IL205425A0 (en)	2010-12-30	Novel pyrimidine derivatives
HRP20140377T1 (en)	2014-05-23	Pyrimidine derivatives
HK1203488A1 (zh)	2015-10-30	嘧啶取代的嘌呤衍生物
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
ZA201100799B (en)	2011-10-26	Imidazopyridin-2-one derivatives
BRPI0907435A2 (pt)	2015-07-14	Derivados de 5-flúor pirimidina
IL210855A (en)	2015-03-31	Annals of Adenine
SG10201506608RA (en)	2015-09-29	3-deazaneplanocin derivatives
ZA201006104B (en)	2012-01-25	Substituted xanthine derivatives
ZA201100876B (en)	2011-10-26	Pyrrolopyridinylpyrimidin-2-ylamine derivatives
ZA201102449B (en)	2011-12-28	Morpholinopurine derivatives
IL210172A0 (en)	2011-03-31	Substituted pyrimidin-4-one derivatives
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
BRPI0920496A2 (pt)	2019-09-24	derivados substituídos de pirimidina etriazina
EP2318378A4 (en)	2012-05-09	quinazoline derivatives
ZA201100948B (en)	2012-04-25	Acylaminobenzamide derivatives
ZA201005382B (en)	2011-10-26	Substituted heteroarylamide diazepinopyrimidone derivatives
IL211290A0 (en)	2011-04-28	New 2-amidothiadiazole derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
IL207191A0 (en)	2010-12-30	Substituted heteroaylamide oxazepyrimidone derivatives
HK1215434A1 (zh)	2016-08-26	取代的嘧啶衍生物
ZA201105050B (en)	2012-03-28	Quinazolinamide derivatives